Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Novartis dives into renin inhibitor research; one compound selected for clinical testing

Sep. 11, 1998

Early clinical results reported for osutidine, an H2 antagonist from Toyama

Sep. 10, 1998

Antisecretory and antiulcer effects of S-0509 characterized in rats

Sep. 10, 1998

KW-5139 effective for reducing gastric stasis following pancreatoduodenectomy

Sep. 10, 1998

Exendin-4 inhibits feeding in rats, indicating potential utility for appetite control in humans

Sep. 10, 1998

MMP inhibitor PGE-2946979 shows good oral antiarthritic activity in rats

Sep. 10, 1998

Efficacy of thiazolidinedione rosiglitazone highlighted at diabetes meeting

Sep. 10, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Synthesis and SAR for piperidine SSNRAs reported at ACS by Parke-Davis/CoCensys

Sep. 10, 1998

Upregulators of LDL receptor in development at Pfizer as hypocholesterolemic agents

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...